Delivery Order SPE2DB24D2003-SPE2DB25FXJW5
- Not listed
- The Defense Logistics Agency awarded a $17,181.12 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,438.54 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.56 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $6,822.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Opzelura 1.5% cream (60 grams). This is a non-set-aside competitive award with an ultimate completion date of July 21, 2025, and performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $26,873.19 delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of May 16, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.26 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram units. This firm fixed-price contract, issued on October 31, 2025, with completion by November 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency for the supply of Opzelura 1.5% Cream in 60-gram units. The contract, valued at $1,310.45, carries a firm fixed price and an ultimate completion date of September 5, 2025. This delivery order represents a non-set-aside competitive award and is executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a Delivery Order (4568090195) to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,480.01 under firm fixed pricing terms, with performance to be completed by May 1, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a ceiling value of $6,776.02 and an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $2,073.05 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units. This firm fixed-price delivery order, with an ultimate completion date of April 25, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical vendor that serves military...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXJW5Delivery Order
The Defense Logistics Agency awarded a $1,513.53 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities. This firm fixed-price contract, which is not set-aside for any specific business category, is scheduled for completion by June 23, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, delivered through competitively awarded contracts. This specific delivery order for Opzelura, a topical pharmaceutical product, reflects the company's continued role in supporting the military healthcare supply chain through the DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/20/25 |